1Heit JA.The epidemiology of venous thromboembolism in the community:implications for prevention and management.J Thromb Thrombolysis 2006; 21:23-29
2Bernstein CN,Blanchard JF,Houston DS,Wajda A.The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease:a population-based cohort study.Thromb Haemost 2001; 85:430-434
3Miehsler W,Reinisch W,Valic E,Osterode W,Tillinger W,Feichtenschlager T,Grisar J,Machold K,Scholz S,Vogelsang H,Novacek G.Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53:542-548
5National Hospital Discharge Survey Multi-year Data File 1979-2003[CD-ROM].Hyattsville,MD:US Dept of Health and Human Services,Center for Disease Control and Prevention,National Center for Health Statistics,2001; 13:19A
7Alikhan R,Cohen AT,Combe S,Samama MM,Desjardins L,Eldor A,Janbon C,Leizorovicz A,Olsson CG,Turpie AG.Prevention of venous thromboembolism in medical patients with enoxaparin:a subgroup analysis of the MEDENOX study.Blood Coagul Fibrinolysis 2003; 14:341-346
8Samama MM.An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients:the Sirius study.Arch Intern Med 2000; 160:3415-3420
9Anderson FA Jr,Wheeler HB,Goldberg RJ,Hosmer DW,Patwardhan NA,Jovanovic B,Forcier A,Dalen JE.A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism.The Worcester DVT Study.Arch Intern Med 1991; 151:933-938
